Photo: Unsplash<\/p>\n
Durham-based therapeutics and product research company Lindy Biosciences has secured $1.6 million in Series A funding, according to company database Crunchbase, topping the citys recent funding headlines. The cash infusion was announced Sept. 18 and led by alumshares.<\/p>\n
According to its Crunchbase profile, \"Lindy is developing high-dose suspension of protein suitable for subcutaneous injection, which will decrease administration costs, increase patient costs, increase patient comfort and compliance, and enable high-dose molecules to reach the market.\"<\/p>\n
The three-year-old startup has raised two previous funding rounds, including a $547,736 seed round earlier this year.<\/p>\n
Over the past year, four Durham-based data and analytics companies have secured venture funding, totaling $32 million in new investment to the local industry.<\/p>\n
In other local funding news, pharmaceutical company Emergo Therapeutics announced a $500,000 debt financing funding round on Oct. 15, financed by North Carolina Biotechnology Center.<\/p>\n
According to Crunchbase, \"Emergo is developing treatment options for flu-like illnesses and to boost the bodys immune system response.\"<\/p>\n
The company also raised a $12 million Series A round in 2018.<\/p>\n
This story was created automatically using local investment data, then reviewed by an editor. Click here for more about what we're doing. Got thoughts? Go here to share your feedback.<\/p>\n
<\/p>\n
Read the original here: Photo: Unsplash Durham-based therapeutics and product research company Lindy Biosciences has secured $1.6 million in Series A funding, according to company database Crunchbase, topping the citys recent funding headlines. The cash infusion was announced Sept. Continue reading
\nDurham funding news: Data and analytics and biotechnology top recent local investments - Yahoo News<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"